Search results
Showing 7426 to 7440 of 7675 results
In development [GID-TA11166] Expected publication date: TBC
In development [GID-TA11089] Expected publication date: TBC
In development [GID-TA11567] Expected publication date: TBC
In development [GID-TA11482] Expected publication date: TBC
In development [GID-TA10745] Expected publication date: 17 July 2024
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation (TA398)
This guidance has been updated and replaced by NICE technology appraisal guidance 988.
Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer [ID6461]
In development [GID-TA11580] Expected publication date: TBC
This guidance has been updated and replaced by NICE interventional procedures guidance 793.
Common mental health problems: identification and pathways to care (CG123)
We withdrew this guideline in May 2024, because all of the recommendations are now covered in other NICE guidelines, or are out of date and no longer relevant to clinical practice. For guidance on common mental health problems, see our guidelines on:
Intrapartum care for healthy women and babies - rectal examination after delivery
Discontinued [GID-NG10395]
Violence and aggression: short-term management in mental health, health and community settings
Discontinued [GID-NG10397]
In development [GID-MT538] Expected publication date: TBC
NICE has withdrawn the med tech innovation briefing (MIB) on Peezy Midstream for urine collection because there is published evidence that shows it offers no clinical benefits over standard care (clean catch method).
The MAGEC system for spinal lengthening in children with scoliosis (MTG18)
August 2024: Following the lifting on the UK suspension of MAGEC system (modified MAGEC X system), NICE's prioritisation board will be reviewing the guidance that was withdrawn in April 2020. We will update this page once a decision is made.
In development [GID-TA11093] Expected publication date: TBC